Living Proof, Valeant Pharma To Market Strateris Skin Lifter To Doctors
Executive Summary
An initial product featuring Living Proof’s Strateris polymer film technology, designed to combat gravity’s effect on aging skin, is slated to launch in March under a joint venture with Valeant Pharmaceuticals. The move will extend Living Proof’s portfolio beyond hair care and provide access to the physician channel.
You may also be interested in...
FDA: “Extreme” Anti-Aging Claims Led To 2012 Warning Letters
A proliferation of “extreme” anti-aging cosmetic claims that crossed the line into drug territory led to FDA’s cluster of warning letters in 2012, according to Jennifer Thomas, director of the division of enforcement in the Center for Food Safety and Applied Nutrition’s office of compliance,
In Brief
Living Proof says it will expand its existing business and fuel R&D with $30 million in new funds from investors; Sen. Frank Lautenberg announces his plan to retire in 2014, with TSCA reform cited as a priority to cap his career. More news in brief.
China Regulatory Probe Slows Nu Skin Growth After Record Year
The firm’s recent explosive growth is expected to slow substantially in the first quarter – to between 20% and 24% – but Nu Skin is confident the steps it is taking in China “make our long-term success more likely.” Analysts have faith in the firm as it works with Chinese officials to resolve an investigation into its business practices.